Merck & Co. (NYSE:MRK) has a market capitalization of $115.52 billion. The company employs 90,000 people, generates revenues of $45,987.00 million and has a net income of $982.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $9,250.00 million. Because of these figures, the EBITDA margin is 20.11 percent (operating margin 3.59 percent and the net profit margin finally 2.14 percent).
The total debt representing 16.90 percent of the company’s assets and the total debt in relation to the equity amounts to 32.89 percent. Due to the financial situation, the return on equity amounts to 1.51 percent. Finally, earnings per share amounts to $1.46 of which $1.52 were paid in form of dividends to shareholders last fiscal.
Here are the price ratios of the company: The P/E ratio is 25.89, Price/Sales 2.46 and Price/Book ratio 2.10. Dividend Yield: 4.53 percent. The beta ratio is 0.67.
| Long-Term Stock Chart Of Merck & Co., Inc. (Click to enlarge) |
Novartis AG (NYSE:NVS) has a market capitalization of $136.46 billion. The company employs 119,418 people, generates revenues of $51,561.00 million and has a net income of $9,969.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $14,941.00 million. Because of these figures, the EBITDA margin is 28.98 percent (operating margin 22.35 percent and the net profit margin finally 19.33 percent).
The total debt representing 18.64 percent of the company’s assets and the total debt in relation to the equity amounts to 36.37 percent. Due to the financial situation, the return on equity amounts to 16.24 percent. Finally, earnings per share amounts to $4.26 of which $2.20 were paid in form of dividends to shareholders last fiscal.
Here are the price ratios of the company: The P/E ratio is 13.37, Price/Sales 2.99 and Price/Book ratio 2.04. Dividend Yield: 4.20 percent. The beta ratio is 0.53.
| Long-Term Stock Chart Of Novartis AG (ADR) (Click to enlarge) |
St. Jude Medical (NYSE:STJ) has a market capitalization of $11.12 billion. The company employs 15,000 people, generates revenues of $5,164.77 million and has a net income of $907.44 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $1,516.04 million. Because of these figures, the EBITDA margin is 29.35 percent (operating margin 24.63 percent and the net profit margin finally 17.57 percent).
The total debt representing 29.32 percent of the company’s assets and the total debt in relation to the equity amounts to 57.45 percent. Due to the financial situation, the return on equity amounts to 23.58 percent. Finally, earnings per share amounts to $2.74 of which $0.00 were paid in form of dividends to shareholders last fiscal.
Here are the price ratios of the company: The P/E ratio is 12.70, Price/Sales 2.01 and Price/Book ratio 2.45. Dividend Yield: 2.58 percent. The beta ratio is 0.75.
| Long-Term Stock Chart Of St. Jude Medical, Inc. (Click to enlarge) |
![]() |
| Best Healthcare Stock Picks For 2012 (Click to enlarge) |

I find that some of the large companies involved in the distribution of over the counter drugs and presrription drugs are a far far better value than merck or St Jude medical
ReplyDeleteOk Dennis, let us know...
ReplyDeleteWe only alert our subscribers once in a long while but when we do you can rest assured we
ReplyDeleteare alerting a Monster Runner right before it moves and our subscribers have plenty of
opportunity to make fast, explosive gains!Stock
Picks.
Excellent and decent post. I found this much informative, as to what I was exactly searching for. Thanks for such post and please keep it up. Wow, this is pretty interesting. Inspiring, as well. Thanks for sharing such inspiring experience with us. Great blog, congrats.!
ReplyDeleteMultibagger stocks